CVE-2022-37461

Public Exploit

Description

Multiple cross-site scripting (XSS) vulnerabilities in Canon Medical Vitrea View 7.x before 7.7.6 allow remote attackers to inject arbitrary web script or HTML via (1) the input after the error subdirectory to the /vitrea-view/error/ subdirectory, or the (2) groupID, (3) offset, or (4) limit parameter to an Administrative Panel (Group and Users) page. There is a risk of an attacker retrieving patient information.

Category

6.1
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 1.02% Top 25%
Vendor Advisory vitalimages.com Vendor Advisory vitalimages.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://www.vitalimages.com/vitrea-vision/vitrea-view/ product vendor advisory
https://www.trustwave.com/en-us/resources/security-resources/security-advisories/?fid=30693 third party advisory exploit
https://www.vitalimages.com/customer-success-support-program/vital-images-software-security-updates/ vendor advisory

Frequently Asked Questions

What is the severity of CVE-2022-37461?
CVE-2022-37461 has been scored as a medium severity vulnerability.
How to fix CVE-2022-37461?
To fix CVE-2022-37461, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-37461 being actively exploited in the wild?
It is possible that CVE-2022-37461 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.